溶栓治疗：现状（2） - Suppr

Suppr

超能文献

Thrombolytic therapy: current status (2).

作者信息

Marder V J, Sherry S

机构信息

Department of Medicine, University of Rochester School of Medicine and Dentistry, N.Y.

出版信息

N Engl J Med. 1988 Jun 16;318(24):1585-95. doi: 10.1056/NEJM198806163182406.

DOI:10.1056/NEJM198806163182406

PMID:3287158

Abstract

摘要

相似文献

Thrombolytic therapy: current status (2).

N Engl J Med. 1988 Jun 16;318(24):1585-95. doi: 10.1056/NEJM198806163182406.

Thrombolytic therapy.

Semin Thromb Hemost. 1984 Jan;10(1):87-103. doi: 10.1055/s-2007-1004411.

[Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases].

Clin Ter. 1975 Jun 15;73(5):403-22.

[Thrombolytic therapy].

Ergeb Inn Med Kinderheilkd. 1965;22:157-210.

Fibrinolytic therapy.

Compr Ther. 1976 Apr;2(4):67-73.

[Further data on therapeutic fibrinolysis].

Helv Med Acta. 1963 Nov;30(4):608-14.

[Thrombolytic therapy].

Internist (Berl). 1992 Apr;33(4):195-6.

Thrombolytic therapy.

Am Heart J. 1977 Mar;93(3):271-3. doi: 10.1016/s0002-8703(77)80243-3.

[The present status of fibrinolytic therapy].

Bull Schweiz Akad Med Wiss. 1973 Nov;29(4):263-75.

[Fibrinolytic therapy].

Hamostaseologie. 2008 Dec;28(5):428-37.

引用本文的文献

High Signal Intensity on Diffusion-Weighted Images Reflects Acute Phase of Deep Vein Thrombus.

Thromb Haemost. 2020 Oct;120(10):1463-1473. doi: 10.1055/s-0040-1714280. Epub 2020 Aug 3.

Production of Bioactive Recombinant Reteplase by Virus-Based Transient Expression System in .

Front Plant Sci. 2019 Oct 8;10:1225. doi: 10.3389/fpls.2019.01225. eCollection 2019.

Recombinant Tissue Plasminogen Activator in the Treatment of Neonates with Intracardiac and Great Vessels Thrombosis.

Pediatr Cardiol. 2015 Dec;36(8):1582-7. doi: 10.1007/s00246-015-1199-0. Epub 2015 May 21.

Bmoo FIBMP-I: A New Fibrinogenolytic Metalloproteinase from Bothrops moojeni Snake Venom.

ISRN Toxicol. 2012 Nov 4;2012:673941. doi: 10.5402/2012/673941. Print 2012.

Viral cirrhosis: an overview of haemostatic alterations and clinical consequences.

Mediterr J Hematol Infect Dis. 2009 Dec 30;1(3):e2009033. doi: 10.4084/MJHID.2009.033.

The effect of the fibrinolytic enzyme FIIa from Agkistrodon acutus venom on acute pulmonary thromboembolism.

Acta Pharmacol Sin. 2011 Feb;32(2):239-44. doi: 10.1038/aps.2010.193.

Thrombolytic therapy for acute pulmonary embolism.

West J Med. 1989 Jul;151(1):67-8.

Pre-clinical studies of plasmin: superior benefit-to-risk ratio of plasmin compared to tissue plasminogen activator.

Thromb Res. 2008;122 Suppl 3(Suppl 3):S9-S15. doi: 10.1016/j.thromres.2008.06.019. Epub 2008 Aug 22.

Ultrasound-enhanced tissue plasminogen activator thrombolysis in an in vitro porcine clot model.

Thromb Res. 2008;121(5):663-73. doi: 10.1016/j.thromres.2007.07.006. Epub 2007 Sep 14.

Diagnosis of aorto-iliac thrombosis in a quarter horse foal using Doppler ultrasound and nuclear scintigraphy.

J Vet Intern Med. 2004 Sep-Oct;18(5):753-6. doi: 10.1892/0891-6640(2004)18<753:doatia>2.0.co;2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Thrombolytic therapy: current status (2).

N Engl J Med. 1988 Jun 16;318(24):1585-95. doi: 10.1056/NEJM198806163182406.

Thrombolytic therapy.

Semin Thromb Hemost. 1984 Jan;10(1):87-103. doi: 10.1055/s-2007-1004411.

[Indications of anticoagulant and fibrinolytic drugs in the prevention and therapy of thromboembolic diseases].

Clin Ter. 1975 Jun 15;73(5):403-22.

[Thrombolytic therapy].

Ergeb Inn Med Kinderheilkd. 1965;22:157-210.

Fibrinolytic therapy.

Compr Ther. 1976 Apr;2(4):67-73.

[Further data on therapeutic fibrinolysis].

Helv Med Acta. 1963 Nov;30(4):608-14.

[Thrombolytic therapy].

Internist (Berl). 1992 Apr;33(4):195-6.

Thrombolytic therapy.

Am Heart J. 1977 Mar;93(3):271-3. doi: 10.1016/s0002-8703(77)80243-3.

[The present status of fibrinolytic therapy].

Bull Schweiz Akad Med Wiss. 1973 Nov;29(4):263-75.

[Fibrinolytic therapy].

Hamostaseologie. 2008 Dec;28(5):428-37.

引用本文的文献

High Signal Intensity on Diffusion-Weighted Images Reflects Acute Phase of Deep Vein Thrombus.

Thromb Haemost. 2020 Oct;120(10):1463-1473. doi: 10.1055/s-0040-1714280. Epub 2020 Aug 3.

Production of Bioactive Recombinant Reteplase by Virus-Based Transient Expression System in .

Front Plant Sci. 2019 Oct 8;10:1225. doi: 10.3389/fpls.2019.01225. eCollection 2019.

Recombinant Tissue Plasminogen Activator in the Treatment of Neonates with Intracardiac and Great Vessels Thrombosis.

Pediatr Cardiol. 2015 Dec;36(8):1582-7. doi: 10.1007/s00246-015-1199-0. Epub 2015 May 21.

Bmoo FIBMP-I: A New Fibrinogenolytic Metalloproteinase from Bothrops moojeni Snake Venom.

ISRN Toxicol. 2012 Nov 4;2012:673941. doi: 10.5402/2012/673941. Print 2012.

Viral cirrhosis: an overview of haemostatic alterations and clinical consequences.

Mediterr J Hematol Infect Dis. 2009 Dec 30;1(3):e2009033. doi: 10.4084/MJHID.2009.033.

The effect of the fibrinolytic enzyme FIIa from Agkistrodon acutus venom on acute pulmonary thromboembolism.

Acta Pharmacol Sin. 2011 Feb;32(2):239-44. doi: 10.1038/aps.2010.193.

Thrombolytic therapy for acute pulmonary embolism.

West J Med. 1989 Jul;151(1):67-8.

Pre-clinical studies of plasmin: superior benefit-to-risk ratio of plasmin compared to tissue plasminogen activator.

Thromb Res. 2008;122 Suppl 3(Suppl 3):S9-S15. doi: 10.1016/j.thromres.2008.06.019. Epub 2008 Aug 22.

Ultrasound-enhanced tissue plasminogen activator thrombolysis in an in vitro porcine clot model.

Thromb Res. 2008;121(5):663-73. doi: 10.1016/j.thromres.2007.07.006. Epub 2007 Sep 14.

Diagnosis of aorto-iliac thrombosis in a quarter horse foal using Doppler ultrasound and nuclear scintigraphy.

J Vet Intern Med. 2004 Sep-Oct;18(5):753-6. doi: 10.1892/0891-6640(2004)18<753:doatia>2.0.co;2.